Diagnostic Algorithms for Chest Pain in General Practice

Abstract

Chest pain is a common yet diagnostically challenging presentation in general practice, necessitating a systematic approach to distinguish benign from life-threatening etiologies. This review synthesizes contemporary diagnostic algorithms, emphasizing evidence-based clinical pathways, epidemiological insights, pathophysiological mechanisms, and guideline-driven recommendations for primary care practitioners. Recent advances and emerging diagnostic modalities are explored, providing a comprehensive, pragmatic framework for optimal patient assessment and management.

Introduction

Chest pain accounts for a significant proportion of consultations in general practice, representing a symptom with a broad differential diagnosis and variable urgency. Prompt, accurate differentiation between cardiac and non-cardiac causes is paramount, as missed acute coronary syndromes or other critical pathologies can result in severe morbidity or mortality. This article aims to equip primary care clinicians with an evidence-based overview of diagnostic algorithms for chest pain, integrating clinical reasoning, risk stratification, and guideline recommendations to enhance decision-making in the primary care setting.

Epidemiology / Disease Burden

Studies indicate that chest pain constitutes up to 1-2% of all consultations in primary care, with prevalence rates varying by geographic region and population demographics. While most presentations are attributable to benign etiologies such as musculoskeletal or gastrointestinal disorders approximately 10% of cases may reflect significant cardiac pathology, including acute coronary syndrome (ACS), pericarditis, or aortic dissection. The diagnostic challenge is compounded by the overlapping symptomatology among cardiac, pulmonary, gastrointestinal, and psychogenic disorders. The burden extends beyond clinical risk to resource utilization, as over-investigation can result in unnecessary referrals, diagnostic testing, and healthcare expenditure.

Pathophysiology

The pathophysiological mechanisms underlying chest pain vary widely. Cardiac causes, such as myocardial ischemia, result from supply-demand mismatch in the coronary circulation, leading to metabolic and electrical disturbances in cardiac myocytes. Non-cardiac etiologies include esophageal spasm, gastroesophageal reflux, pleuritic inflammation, musculoskeletal strain, and anxiety-induced hyperventilation. The convergence of visceral and somatic afferent pathways at the spinal cord level often results in non-specific pain localization, further complicating clinical assessment. Understanding these mechanisms is critical for the application of tailored diagnostic algorithms in general practice.

Risk Factors

Effective risk stratification hinges on the identification of key risk factors. Traditional cardiovascular risk factors age, male sex, hypertension, diabetes mellitus, dyslipidemia, smoking, and family history should be systematically assessed. Additional clinical features such as history of prior coronary artery disease, recent exertion, or known hypercoagulable states further inform the likelihood of serious pathology. For non-cardiac causes, risk factors include recent respiratory infections (for pleuritis), trauma or physical exertion (for musculoskeletal pain), and reflux-inducing dietary habits (for gastrointestinal origins).

Clinical Features

Detailed history and physical examination remain the cornerstone of chest pain evaluation. Cardiac pain is typically described as retrosternal pressure or tightness, often radiating to the arm, neck, or jaw, and may be precipitated by exertion or emotional stress. Associated symptoms such as diaphoresis, dyspnea, or syncope increase the suspicion for ACS. Conversely, pleuritic, sharp, or localized pain exacerbated by movement or palpation is more consistent with musculoskeletal or pleuropulmonary causes. Gastrointestinal pain may be described as burning or epigastric discomfort, often related to meals or positional changes. Psychogenic pain may present with atypical features and a chronic, waxing-waning course.

Diagnosis

Diagnostic algorithms in general practice are structured to rapidly identify life-threatening conditions while minimizing unnecessary referrals. Initial assessment includes vital sign evaluation, risk factor analysis, and application of validated clinical decision rules such as the Marburg Heart Score, TIMI, or HEART score. Electrocardiography (ECG) and point-of-care troponin testing, where available, aid in the exclusion of ACS. In low-risk patients with non-specific features, a watchful waiting or structured follow-up approach may be justified. When atypical or concerning features are present, prompt referral to secondary care for further cardiac imaging or laboratory testing is warranted. Algorithms also incorporate exclusion of pulmonary embolism and aortic dissection based on clinical gestalt and risk scores (e.g., Wells, Geneva, or aortic dissection detection risk score).

Treatment & Management

Management is dictated by the underlying etiology. For suspected ACS, urgent transfer to emergency services is mandatory, with initiation of aspirin and other guideline-directed therapies as indicated. Musculoskeletal pain may be managed with analgesics, physical therapy, and reassurance. Gastroesophageal causes benefit from proton pump inhibitors or antacids, alongside lifestyle modifications. Anxiety-related chest pain requires a biopsychosocial approach, often incorporating cognitive-behavioral therapy. Regardless of etiology, clear safety-netting instructions and follow-up plans are essential to ensure patient safety.

Recent Advances / Emerging Therapies

Recent advances in diagnostic pathways for chest pain include high-sensitivity troponin assays, which allow for rapid rule-out protocols and reduced unnecessary admissions. The integration of artificial intelligence and machine learning into ECG interpretation and risk stratification tools shows promise in enhancing diagnostic accuracy. Novel point-of-care imaging modalities, such as handheld echocardiography, are being evaluated for their feasibility in primary care. These innovations, while promising, require robust validation in real-world general practice settings before widespread implementation.

Guideline Recommendations

International guidelines, including those from the National Institute for Health and Care Excellence (NICE), American Heart Association (AHA), and European Society of Cardiology (ESC), emphasize a structured, stepwise approach to chest pain in primary care. Key recommendations include immediate identification and referral of patients with red flag features, use of validated risk assessment tools, and judicious application of diagnostic testing. Shared decision-making and patient education are highlighted as integral components of the diagnostic process. Guidelines also stress the importance of continuing professional development for primary care clinicians in the recognition and management of chest pain syndromes.

Conclusion

Chest pain remains a diagnostically complex presentation in general practice, demanding a systematic, evidence-based approach to maximize patient safety and resource efficiency. The application of structured diagnostic algorithms, informed by epidemiology, pathophysiology, and risk stratification, is essential for the timely identification of serious pathology. Ongoing advances in diagnostic modalities and the refinement of clinical decision rules continue to evolve the landscape of chest pain assessment, underscoring the need for ongoing education and adherence to guideline-based care in the primary care setting.